FDA approved FILSUVEZ® topical gel for the treatment of partial thickness wounds in patients 6 months and older with JEB and DEB.
Chiesi Global Rare Diseases, a business unit of the Chiesi Group established to deliver innovative therapies and solutions for people affected by rare diseases, announced today that FDA approved FILSUVEZ® (birch triterpenes) topical gel for the treatment of partial thickness…